ロード中...
Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation
Treatment with β-adrenoceptor agonists does not fully overcome the symptoms associated with severe asthma. Serelaxin elicits potent uterine and vascular relaxation via its cognate receptor, RXFP1, and nitric oxide (NO) signaling, and is being clinically evaluated for the treatment of acute heart fai...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5081476/ https://ncbi.nlm.nih.gov/pubmed/27833558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00406 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|